Evidence map›Paper›PMID 36432382›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Novel PEPPSI-Type NHC Pd(II) Metallosurfactants on the Base of 1H-Imidazole-4,5-dicarboxylic Acid: Synthesis and Catalysis in Water-Organic Media.

Vladimir Burilov, Dmitriy Radaev, Elza Sultanova, Diana Mironova, Daria Duglav, Vladimir Evtugyn, Svetlana Solovieva, Igor Antipin

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vladimir BurilovKazan Federal University, 18 Kremlevskaya St., 420008 Kazan, Russia.ORCID 0000-0001-7089-3340
Dmitriy RadaevKazan Federal University, 18 Kremlevskaya St., 420008 Kazan, Russia.
Elza SultanovaKazan Federal University, 18 Kremlevskaya St., 420008 Kazan, Russia.ORCID 0000-0001-8796-4352
Diana MironovaKazan Federal University, 18 Kremlevskaya St., 420008 Kazan, Russia.ORCID 0000-0003-1943-3300
Daria DuglavKazan Federal University, 18 Kremlevskaya St., 420008 Kazan, Russia.
Vladimir EvtugynInterdisciplinary Center for Analytical Microscopy, Kazan Federal University, 18 Kremlevskaya St., 420008 Kazan, Russia.
Svetlana SolovievaArbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center of RAS, 8 Arbuzov Str., 420008 Kazan, Russia.
Igor AntipinKazan Federal University, 18 Kremlevskaya St., 420008 Kazan, Russia.

Funding

Russian Science Foundation 22-13-00304
6 · The paper itself

Abstract

Carrying out organic reactions in water has attracted much attention. Catalytic reactions in water with metallosurfactants, which have both a metallocenter and the surface activity necessary for solubilizing hydrophobic reagents, are of great demand. Herein we proposed new approach to the synthesis of NHC PEPPSI metallosurfactants based on the sequential functionalization of imidazole 4,5-dicarboxylic acid with hydrophilic oligoethylene glycol and lipophilic alkyl fragments. Complexes of different lipophilicity were obtained, and their catalytic activity was studied in model reduction and Suzuki-Miyaura reactions. A comparison was made with the commercial PEPPSI-type catalytic systems designed by Organ. It was found that the reduction reaction in an aqueous solution of the metallosurfactant with the tetradecyl lipophilic fragment was three times more active than the commercially available PEPPSI complexes, which was associated with the formation of stable monodisperse aggregates detected by DLS and TEM.

Indexed as

aggregationNHCPEPPSI complexp-nitrophenol reductionSuzuki–Miyaura coupling

Identifiers

PMID36432382
PMCPMC9694788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.